UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | E | F | G | H | K | L | M | P | R | S | T | U | W | Z
Number of items: 55.

A

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Waud, WR; Hartley, JA; Howard, PW; ... Sausville, EA; + view all (2002) Efficacy evaluations of SJG-136 (NSC 694501), a novel pyrrolobenzodiazepine dimer with broad spectrum antitumor activity. In: Proc Am Assoc Cancer Res. (pp. 315 - ?).

Ardeshna, K; Smith, P; Norton, A; Hancock, B; Hoskin, PJ; (2002) The long term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkin's lymphoma: results of a British National Lymphoma randomized trial. In: Annals Of Oncology. (pp. 76 - ?).

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Batter, V; Coleman, R; ... Cofer, T; + view all (2002) Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. Breast Cancer Research and Treatment , 76 138 - ?.

B

Bentzen, SM; Saunders, MI; Dische, S; (2002) From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome. Clinical Oncology , 14 (5) 372 - 381.

Boddy, AV; Todd, R; Verrill, M; Sludden, J; Fishwick, K; Robson, L; ... Calvert, AH; + view all (2002) Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study. European Journal of Cancer , 38 98 - ?.

Braybrooke, JP; Slade, A; Gibson, R; Deplanque, G; Madhusudan, S; Makris, A; (2002) Phase one study of MetXia-P450 gene therapy for patients with advanced breast cancer or melanoma. In: Proceedings ASCO. (pp. 22a - ?).

Burcombe, RJ; Makris, A; Wilson, GD; (2002) Evaluation of topoisomerase II-alpha as a predictor of clinical and pathological response to neoadjuvant chemotherapy in operable breast cancer. In: Proceedings ASCO. (pp. 447a - ?).

Burger, AM; Fiebig, HH; Hagan, DR; Tiberghien, A; Howard, PW; Schultz, R; ... Thurston, DE; + view all (2002) The monomer pyrrolobenzodiazepine (PBD) DNA minor-groove binding agent DRH-417 (NSC 709119) shows pre-clinical activity in human renal cell carcinoma. In: Proceedings of the American Association of Cancer Research. (pp. 5719 - ?).

C

Chow, E; Coia, L; Wu, J; Nanjan, N; Kirkbride, P; Hoskin, PJ; (2002) Debate: this house believes that multiple-fraction radiotherapy is a barrier to referral for palliative radiotherapy for bone metastases. Current Oncology , 9 60 - 66.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. International Journal of Cancer 7 - 7.

Cooke, SP; Pedley, RB; Boden, R; Begent, RH; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Bioconjug Chem , 13 (1) 7 - 15.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. Bioconjugate Chemistry , 13 (1) 7 - 15.

E

El-Emir, E; Petrie,; I, A; Boxer,; G, M; Boden,; ... R, HJAPRB; + view all (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 257 - ?).

F

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; ... R, HJ; + view all (2002) . A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 1249 - 1257.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Bhatia, J; ... Begent, RHJ; + view all (2002) Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. International Journal of Radiation Biology , 78 (5) 407 - 415.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2002) Antibody and radionuclide characteristics can enhance the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. International Journal of Radiation Biology , 78 407 - 415.

G

Gupta, N; Saleem, A; Osman, S; Hoskin, P; Price, PM; Aboagye, EO; (2002) Carbogen and nicotinamide selectively increase chemotherapy delivery and blood flow to liver metastasis. British Journal of Cancer , 86 S14 - S14.

H

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A Phase I/II Study of CHARTWEL with concurrent chemotherapy in locally advanced inoperable carcinoma of the oesphagus. In: Radiotherapy And Oncology. (pp. S27 - ?).

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A phase II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. In: Radiotherapy And Oncology. (pp. 83 - ?).

Harney, J; Shah, N; Joiner, M; Short, S; Saunders, MI; (2002) Low dose hyper-sensitivity- does it occur in normal skin? In: Proc 21st Annual ESTRO meeting, Prague 2002.

Harney, J; Shah, N; Short, SC; Joiner, M; Saunders, MI; (2002) Low dose hyper-radiosensitivity - does it exist in normal skin? In: Radiotherapy And Oncology. (pp. S57 - ?).

Harney, J; Short, SC; Saunders, MI; (2002) Low dose hyper-radiosensitivity - A clinical assessment. In: British Journal of Cancer. (pp. S56 - ?).

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; ... Thurston, DE; + view all (2002) In vitro antitumor activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: Proceedings of the American Association of Cancer Research. (pp. 2432 - ?).

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; ... D, E; + view all (2002) In vitro activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 489 - ?).

Hoskin, P; (2002) Secondary malignancies after radiotherapy. The Lancet Oncology , 3 (9) 577 - 578.

Hoskin, PJ; (2002) Conformal radiotherapy to the prostate: are bigger fields better? Clinical Oncology , 14 (4) 296 - 297.

Hoskin, PJ; (2002) Tumour hypoxia and vascularity in lymphoma. In: Annals Of Oncology. (pp. 615 - ?).

Hoskin, PJ; (2002) Radiotherapy in cancer pain management. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (253 - 258). : London.

Hoskin, PJ; (2002) Radiotherapy in palliative care. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (281 - 292). Arnold: London.

Hoskin, PJ; Grover, A; Bhana, R; (2002) Optimal radiotherapy dose for metastatic spinal canal compression. British Journal of Cancer , 86 S20 - S20.

Hoskin, PJ; Morgan, DAL; Robinson, M; (2002) Erythropoetin supplementation for radical radiotherapy in head and neck cancer: an interim analysis of a randomized phase III trial. In: Radiotherapy And Oncology. (pp. 83 - ?).

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; ... Lee, M; + view all (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso- cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco- cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. Bioorganic and Medicinal Chemistry , 10 (9) 2941 - 2952.

K

Kirkby, N; Faraday, DBF; Short, S; C, W; M, J; M C, B; N, G; (2002) Mathematical modelling to develop a novel radiotherapy schedule for high grade brain tumours, based on phase distribution of low-dose hypersensitivity in human glioma cell lines. In: Proc 21st Annual ESTRO meeting, Prague 2002.

L

Lee, SM; James, LE; Mohamed-Ali, V; Boschoff, C; Snee, M; Brock, C; ... Prendiville, J; + view all (2002) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) Oral presentation. 2002 ASCO Annual Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1251 - ?). Proceedings of the American Society of Clinical Oncology

M

Makris, A; Burcombe, RJ; Wilson, GD; Richman, PI; Allen, S; Wright, D; Pittam, M; (2002) Comparison of clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy for primary breast cancer. European Journal of Cancer , 38 268 - ?.

McHugh, PJ; Kiakos, K; Hartley, JA; Lee, M; (2002) The Rad6 pathway is involved in the nucleotide excision repair of DNA minor groove adducts. In: Proceedings of the American Association of Cancer Research. (pp. 5103 - ?).

P

Pedley, RB; Sharma, SK; Chester, KA; (2002) Antibody-directed Enzyme Prodrug Therapy. In: Suicide Gene Therapy: Methods and Protocols for Cancer. Humana Press

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, J; ... Boden, RABRHJ; + view all (2002) The spatial accuracy of 3D reconstructed radioluminographs on serial tissue sections and the resultant absorbed dose estimates. Physics in Medicine and Biology , 47 3651 - 3661.

R

Rojas, A; Saunders, MI; (2002) Addition of chemotherapy to altered fractionation schedules in non-small cell lung cancer. In: Kogelnik, HD and Lukas, P and Sedlmayer, F, (eds.) Progress in Radio-oncology VII. (437 - 445). Monduzzi

Rojas, A; Saunders, MI; (2002) ARCON in clinical radiotherapy. In: Kogelnik, HD and Lukas, P and Sedlmayer, F, (eds.) Progress in Radio-oncology. (89 - 98).

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; et, A; (2002) A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer. In: (Proceedings) Oral presentation. 2002 Annual ASCO Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1164 - ?). Proceedings of the American Society of Clinical Oncology

S

Saunders, MI; (2002) Chart and chemotherapy. Clinical Oncology , 14 (4) 331 - 332.

Sharma, SK; Pedley, RB; Bhatia, J; Irwin, HL; El-Emir, E; Boxer, GM; ... R, HJ; + view all (2002) Antibody-directed enzyme prodrug therapy (ADEPT): comparison in two colorectal carcinoma xenografts. In: (Proceedings) proceedings AmericanAssociation for Cancer Research. (pp. 943 - ?).

Short, SC; Harney, J; Dopson, F; Saunders, MI; (2002) The effects of low-dose fractionated radiation on sarcomas- experimental and clinical data. British Journal of Cancer , 86 S56 - S57.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2002) Hypoxia in bladder cancer: Validation of intrinsic markers with pimonidazole and their influence on clinical outcome after accelerated radiotherapy with carbogen and nicotinamide. British Journal of Cancer , 86 S28 - S29.

Southworth, R; Dearling, J; Medina, R; Flynn, A; Pedley, RBAG; P,; (2002) 18FDG and 14C DG6P accumulation differ in the isolated heart: an autoradiographic study. In: J Mol. Cell. Cardiol. (pp. 59 - ?).

Spalding, DRC; Hochhauser, D; Hartley, J; Davidson, B; (2002) Heterogeneity of response to chemotherapy in liver tumours evaluated by the comet assay in an isolated perfused human liver. British Journal Of Surgery , 89 50 - 50.

Szekely, Z; Kosakowska-Cholody, T; Hartley, JA; Michejda, CJ; (2002) Coupling minor groove binders with intercalators, an attempt to design chemical gene knockout agents. In: Proceedings of the American Association of Cancer Research. (pp. 2428 - ?).

T

Thomas, R; Makris, A; Bloomfield, D; Godward, S; Moody, M; (2002) Empowering patients to make informed treatment decisions based on tolerability, quality of life patient preference. A comparison of letrozole and anastrazole in a multicentre, randomised, single-blind cross over study. European Journal of Cancer , 38 171 - ?.

Trent, S; Kong, A; Short, SC; Traish, D; Ashley, S; Dowe, A; ... Brada, M; + view all (2002) Temozolomide as second-line chemotherapy for relapsed gliomas. Journal of Neuro-Oncology , 57 (3) 247 - 251.

U

UCL, 22AR; (2002) Achievements: UCL's academics conducted pioneering work at the forefront of their disciplines during this year. 12 - 13.

UCL, PS; (2002) Thalidomide to be used in cancer fight. 44 - ?.

W

Winfield, E; Deighton, A; Venables, K; Hoskin, PJ; Aird, EGA; (2002) Survey of UK breast radiotherapy techniques: Background prior to the introduction of the quality assurance programme for the START (Standardisation of Radiotherapy) Trial in breast cancer. Clinical Oncology , 14 (4) 267 - 271.

Wong, WL; Campbell, H; Saunders, M; (2002) Positron emission tomography (PET) - Evaluation of 'indeterminate pulmonary lesions'. Clinical Oncology , 14 (2) 123 - 128.

Z

Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEM BIOPH RES CO , 296 (1) 178 - 181.

This list was generated on Sun May 17 03:51:07 2015 BST.